By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Psychotherapeutic combinations > Lybalvi
Psychotherapeutic combinations

Lybalvi

https://themeditary.com/drug/lybalvi-2202.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: olanzapine and samidorphan

Drug class: Psychotherapeutic combinations

Dosage form: tablets

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Olanzapine and samidorphan

Contents
Uses Warnings Before Taking Dosage Side effects Interactions
  • Lybalvi (Olanzapine and samidorphan)-OS 5-olanzapine 5 mg / samidorphan 10 mg-Yellow-Capsule-shape Lybalvi olanzapine 5 mg / samidorphan 10 mg (OS 5)
  • Lybalvi (Olanzapine and samidorphan)-OS 10-olanzapine 10 mg / samidorphan 10 mg-Orange-Capsule-shape Lybalvi olanzapine 10 mg / samidorphan 10 mg (OS 10)
  • Lybalvi (Olanzapine and samidorphan)-OS 15-olanzapine 15 mg / samidorphan 10 mg-Blue-Capsule-shape Lybalvi olanzapine 15 mg / samidorphan 10 mg (OS 15)
  • Lybalvi (Olanzapine and samidorphan)-OS 20-olanzapine 20 mg / samidorphan 10 mg-Pink-Capsule-shape Lybalvi olanzapine 20 mg / samidorphan 10 mg (OS 20)
  • View all images

What is Lybalvi?

Lybalvi is a prescription medicine which contains two medicines (olanzapine and samidorphan) used in adults:

  • to treat schizophrenia
  • alone for short-term (acute) or maintenance treatment of manic or mixed episodes that happen with bipolar I disorder
  • in combination with valproate or lithium to treat manic or mixed episodes that happen with bipolar I disorder

It is not known if this medicine is safe or effective in children.

Warnings

Lybalvi may cause serious side effects, including:

  • Increased risk of death in elderly people with dementia related psychosis. Lybalvi increases the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).
    Lybalvi is not approved for the treatment of people with dementia-related psychosis.

If your healthcare provider prescribes Lybalvi in combination with valproate or lithium, also read the Medication Guide that comes with those medicines.

Who should not take Lybalvi?

You should not take this medicine if you are taking opioids or are experiencing acute opioid withdrawal. See Lybalvi side effects.

Lybalvi pregnancy and breastfeeding warnings (more detail)

Before taking Lybalvi

Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:

  • have or had heart problems or a stroke
  • use or abuse street (illegal) drugs
  • have or had low or high blood pressure
  • have kidney problems
  • have diabetes or high blood sugar or a family history of diabetes or high blood sugar
  • have or have had high levels of total cholesterol, LDL cholesterol, or triglycerides or low levels of HDL cholesterol
  • have or had a low white blood cell count
  • have problems swallowing
  • have or had seizures (convulsions)
  • have or had problems with urination or prostate problems
  • have or had breast cancer
  • have or had constipation or a bowel obstruction
  • have or had high prolactin levels
  • are pregnant or plan to become pregnant. Talk to your healthcare provider about the risks to you and your unborn
    or newborn baby if you take Lybalvi during pregnancy.
    • Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment.
    • If you become pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and research-programs/pregnancyregistry/
  • are breastfeeding or plan to breastfeed. Lybalvi passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Lybalvi and other medicines may affect each other causing possible serious side effects. Lybalvi may affect the way other medicines work, and other medicines may affect how Lybalvi works.

Especially tell your healthcare provider if you:

  • take opioids or have stopped taking opioids in the past 14 days
  • take or plan to take other olanzapine containing medicines

Your healthcare provider can tell you if it is safe to take Lybalvi with your other medicines. Do not start or stop any medicines while taking Lybalvi without first talking to your healthcare provider.
Know the medicines you take. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.

How should I use Lybalvi

  • Take Lybalvi exactly as your healthcare provider tells you to take it. Do not change the dose or stop treatment without first talking to your healthcare provider.
  • Take Lybalvi tablets one time each day with or without food.
  • Swallow the tablets whole. Do not split or combine different strength tablets.
  • If you take too much or overdose, call your Poison Control Center at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Detailed Lybalvi dosage information
Lybalvi Dosage information (more detail)

Before Taking

You should not take this medicine if you are taking opioids or are experiencing acute opioid withdrawal. See Lybalvi side effects.

Lybalvi pregnancy and breastfeeding warnings (more detail)

Before taking Lybalvi

Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:

  • have or had heart problems or a stroke
  • use or abuse street (illegal) drugs
  • have or had low or high blood pressure
  • have kidney problems
  • have diabetes or high blood sugar or a family history of diabetes or high blood sugar
  • have or have had high levels of total cholesterol, LDL cholesterol, or triglycerides or low levels of HDL cholesterol
  • have or had a low white blood cell count
  • have problems swallowing
  • have or had seizures (convulsions)
  • have or had problems with urination or prostate problems
  • have or had breast cancer
  • have or had constipation or a bowel obstruction
  • have or had high prolactin levels
  • are pregnant or plan to become pregnant. Talk to your healthcare provider about the risks to you and your unborn
    or newborn baby if you take Lybalvi during pregnancy.
    • Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment.
    • If you become pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and research-programs/pregnancyregistry/
  • are breastfeeding or plan to breastfeed. Lybalvi passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Lybalvi and other medicines may affect each other causing possible serious side effects. Lybalvi may affect the way other medicines work, and other medicines may affect how Lybalvi works.

Especially tell your healthcare provider if you:

  • take opioids or have stopped taking opioids in the past 14 days
  • take or plan to take other olanzapine containing medicines

Your healthcare provider can tell you if it is safe to take Lybalvi with your other medicines. Do not start or stop any medicines while taking Lybalvi without first talking to your healthcare provider.
Know the medicines you take. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.

Related/similar drugs

Caplyta, quetiapine, Abilify, lamotrigine, Seroquel, aripiprazole, risperidone

What should I avoid while using Lybalvi?

  • Do not drive a car, operate machinery, or do other dangerous activities until you know how Lybalvi affects you. Lybalvi may make you feel drowsy.
  • Avoid drinking alcohol during treatment.
  • Avoid getting over-heated or dehydrated.
    • Do not exercise too much.
    • In hot weather, stay inside in a cool place if possible.
    • Stay out of the sun. Do not wear too much clothing or heavy clothing.
    • Drink plenty of water.

Lybalvi side effects

Lybalvi may cause serious side effects, including:

  • See Important information
  • Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
  • Opioid withdrawal. Do not take Lybalvi for at least 7 days after you stopped taking short-acting opioids and for at least 14 days after you stopped taking long-acting opioids. One of the medicines in Lybalvi (samidorphan) can cause opioid withdrawal that may be severe and cause hospitalization in people who are physically dependent on opioids. Talk to your healthcare provider if you have questions about the type of opioid you take.
  • Risk of life-threatening opioid overdose. You should not start taking opioids for at least 5 days after you stop treatment with Lybalvi. One of the medicines in Lybalvi (samidorphan) can increase your chance of having an opioid overdose that can cause death if you take opioids during treatment or within 5 days after stopping treatment with Lybalvi.
    You can accidentally overdose in 2 ways:
    • Lybalvi blocks the effects of opioids, such as heroin, methadone, or opioid pain medicines. Do not take large amounts of opioids to try to overcome the opioid-blocking effects of Lybalvi. This can lead to serious injury, coma, or death.
    • After you take Lybalvi, its blocking effect slowly decreases and completely goes away over time. You may be more sensitive to the effects of opioids. If you have used opioid street drugs or opioid-containing medicines in the past, using opioids in amounts that you used before treatment with Lybalvi can lead to overdose or death.

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the
risk of overdose.
You or someone close to you should get emergency medical help right away if you:

    • have trouble breathing
    • become very drowsy with slowed breathing
    • have slow, shallow breathing (little chest movement with breathing)
    • feel faint, very dizzy, confused, or have unusual symptoms

Tell your healthcare provider if you are taking Lybalvi before a medical procedure or surgery.

  • Neuroleptic malignant syndrome (NMS), a serious condition that can lead to death. Call your healthcare provider or go to the nearest hospital emergency room right away if you have some or all of the following signs and symptoms of NMS:
    • high fever
    • stiff muscles
    • confusion
    • sweating
    • changes in your breathing, pulse, heart rate, and blood pressure
  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): One of the medicines in Lybalvi (olanzapine) can cause DRESS which can cause death. Tell your healthcare provider right away if you develop any of the following symptoms of DRESS, including:
    • rash
    • swollen glands
    • liver problems
    • heart problems
    • fever
    • kidney problems
    • lung problems
  • Problems with your metabolism such as:
    • high blood sugar (hyperglycemia) and diabetes. Increases in blood sugar can happen in some people who take Lybalvi. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before you start and regularly during treatment.
      Call your healthcare provider if you have any of these symptoms of high blood sugar during treatment:
      • feel very thirsty
      • feel very hungry
      • feel sick to your stomach
      • need to urinate more than usual
      • feel weak or tired
      • feel confused, or your breath smells fruity
    • increased fat levels (cholesterol and triglycerides) in your blood. Your healthcare provider should check the fat levels in your blood before you start and regularly during treatment.
    • weight gain. You and your healthcare provider should check your weight before you start and often during treatment.
  • Uncontrolled body movements (tardive dyskinesia). Lybalvi may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking Lybalvi. Tardive dyskinesia may also start after you stop taking Lybalvi.
  • Decreased blood pressure (orthostatic hypotension) and fainting. You may feel lightheaded or faint when you rise too quickly from a sitting or lying position.
  • Falls. Lybalvi may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause fractures or other injuries.
  • Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment.
  • Difficulty swallowing that can cause food or liquid to get into your lungs.
  • Seizures (convulsions).
  • Problems controlling your body temperature so that you feel too warm. See What should I avoid while taking Lybalvi?
  • Increased prolactin levels in your blood. Your healthcare provider may do blood tests to check your prolactin levels during treatment.

The most common side effects when used to treat people with schizophrenia include:

  • weight gain
  • dry mouth
  • sleepiness
  • headache

The most common side effects when used alone to treat people with mixed or manic episodes that happen with bipolar I disorder include:

  • weakness
  • constipation
  • sleepiness
  • shaking
  • dry mouth
  • increased appetite
  • dizziness

The most common side effects when used in combination with lithium or valproate to treat people with mixed or manic episodes that happen with bipolar I disorder include:

  • dry mouth
  • increased appetite
  • back pain
  • problems speaking
  • memory problems
  • weight gain
  • dizziness
  • constipation
  • mouth watering
  • numbness and tingling in your arm and legs

These are not all the possible side effects. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA1088.

See more: Lybalvi Side Effects

What other drugs will affect Lybalvi?

Other drugs may interact with olanzapine and samidorphan, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

More about Lybalvi (Olanzapine and samidorphan)

Dosage information
Lybalvi Side Effects
During pregnancy
Lybalvi Prescribing Information
Drug images
Side effects
Drug class: Psychotherapeutic combinations

Related treatment guides

Bipolar Disorder
Schizophrenia
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by